Will Hahn Email & Phone Number

Sacramento, California, Us

As the Director of Strategy and Business Development, I design and execute enterprise-wide initiatives and market-oriented projects targeting growth opportunities for outpatient and inpatient services, and the Sutter Health insurance plan in San Mateo, Santa Clara, and Santa Cruz counties.• Appointed the Sutter-wide lead for bundled payment programs, including clinical care transformation efforts. On-target to realize $22M in net savings over 5 years.• Leading role in driving growth through transformational initiatives, clinical service lines, strategic partnerships, and business development deals.

Mountain View, Ca, Us

I led cross-functional teams on enterprise-wide initiatives and divisionally-oriented projects improving clinical outcomes, enhancing the experience of patients, reducing the total cost of care, expanding services and market share, and promoting the engagement of people throughout the organization. Recent contributions and accomplishments included: • Nominated for the Leadership Academy, Sutter Health's most prestigious professional development program • Led design and implementation of an innovative behavioral health program integrated with primary care and delivering $120M in projected savings across the region• Led Revenue Cycle enhancement efforts, generating over $6.7M in incremental revenue per annum• Managed lean implementation across 37 departments (i.e., daily management system, A3 thinking, standard work, tiered metrics, and visual management) • Led strategic partnership with local FQHCs resulting in over $2.0M of community benefit fundingDuring my tenure in this role, the organization became a state-recognized leader in clinical quality and patient satisfaction, significantly reduced costs and prices, fundamentally transformed management practices and operating systems, and expanded market share to improve the health and well-being of over 50% of the Santa Cruz community.

Despite a 40% reduction in total revenue due to the state-wide elimination of Medi-Cal's optional benefits, my team and I transformed this Federally Qualified Health Center (FQHC) through innovation and operational improvements. We grew market share by 45%, improved the value of patient care (better quality at a lower cost), delivered record profitability, increased the cash reserve by over 200%, and developed our people into a high-functioning team. I worked with the Board of Directors to ensure strong financial statements, clean audits, and a comprehensive 5-year strategic plan. This plan transformed the business model and resulted in the launch of mobile clinics at 14 sites (elementary schools, WIC offices, and skilled nursing facilities) and the implementation of multiple technologies (EHR, digital x-ray, and IT disaster recovery systems). I represented the FQHC clinic and the local health improvement coalition in state legislative advocacy.

Washington, Dc, Us

Worked directly with 30 member Board of Directors and Senior Executive Team to lead strategic planning and programmatic growth of a renowned professional medical society. Grew revenues from $65M to $95M over 2.5 years in new and existing markets, identified over $4.5M in annual savings, and increased staff from 200 to over 300 FTEs. Developed five-year vision for organization with specific goals and objectives, including implementation of the Balanced Scorecard methodology.

Healthcare strategic management consulting, focused on business strategy formulation, clinical transformation, and performance improvement engagements. • Helped establish a management strategy consulting practice for the healthcare division of a Fortune 500 company. My responsibilities included profit/loss, client & project management, recruitment, and daily operations of national consulting practice.• Conducted the process redesign for an EPIC implementation at Kaiser Permanente's Southern California region, personally identifying over $700M in future benefits via performance optimization. Worked with the senior leadership team (VPs to the joint CEOs).• Led a strategic planning engagement for a community hospital, working with the CEO and executive team to analyze business performance and develop strategic objectives with tactical plans for mission critical initiatives over a 3-year period. • Generated over $500K in client sales through numerous work opportunities identified and responses to RFI and RFP.

Worldwide, Oo

Strategy & Operations, healthcare practice• Led the process redesign for HealthSouth's Surgery Division (over $1B in annual net revenue) as part of a turnaround effort resulting in the client successfully being relisted on the NYSE. Redesigned business processes (Rev Cycle, Purchasing, Inventory, Payroll, Fixed Assets, etc.) and conducted training, implementation and monitoring of 180+ ASCs and 3 Surgical Hospitals for SOX compliance. Managed teams of 5-20 people, led training sessions with audiences of 100+ attendees, and regularly presented to executive leadership. Realized $70M in annual savings.• Led strategic planning for 5 hospital service lines at the University of Kentucky's Medical Center (Digestive Health, OB/Newborn, Ophthalmology, Endocrinology/Nutrition, and Infectious Disease) with best practices and associated financial and operational impact.• Responsible for development of business plans for 15 separate hospital service lines, including financial analysis and tactical work steps. Worked with executive and physician leadership to reach consensus and board approval.

Healthcare strategy consulting firm serving the healthcare vertical. Responsibilities and accomplishments included:• Led the analysis of market trends, profit potential and inpatient/outpatient utilization growth for six major hospital service lines as part of a strategic planning engagement with Hospital Corporation of America/HCA. Service lines included Cardiovascular, Orthopedics, Oncology, Neurosciences, General Surgery, and Diagnostic Imaging. Partnered with Sg-2 to develop forecasts and adoption strategies regarding emerging medical technologies. • Developed a comprehensive corporate strategy for a leading Third Party Administrator (TPA), managing all aspects of the business planning process from budget allocation to the creation of key performance metrics.• Led sales force redesign for the nations leading wholesale PPO network organization by aligning internal capabilities to new market opportunities, redefining sales roles and minimizing channel conflict.• Managed new market development plan and business impact forecast through customer segmentation within corporate strategic planning process for the nation’s largest health care provider network.

• Coordinated a cross-functional team of 10 people (consulting, finance, marketing, sales, technical design) to develop a business plan, enabling IBM brands to pursue a $20B IT opportunity in the health care market. • Designed a $2.5B value capture model for data management solutions by conducting market sizing, customer segmentation, portfolio analysis, environmental and competitive analysis. • Identified and defined a high-revenue growth opportunity in the knowledge management domain, valued at $700M. Developed a global service recommendation to demonstrate IBM’s value of IT solutions for sales training and customer enablement. Presented all findings to senior executives

Biotech firm specializing in the discovery and development of protein-based drug therapies via directed evolution technology. This firm has since been acquired by Eli Lilly.• Worked within a cross-functional team to develop second generation medications for FDA approved drugs, designing and conducting research using directed evolution for protein-based drug therapies (antibodies and enzymes). Regularly presented findings and recommendations to senior management. • Participated in development of Numax, reducing production costs 1000% to address new target markets (infants and geriatrics) with potential annual revenues of $900M. • Increased accuracy and consistency of a key quantitation technique, reducing costs by 20% and time by 200%. Won approval from senior management for company wide integration.

Biotech firm focused on discovery and development of antibody therapies via phage display technologies. This firm has since been acquired by Alexion Pharmaceuticals.• Generated antibody libraries for immunotherapy targets, the primary interest in a $40 million acquisition negotiated with Alexion Pharmaceuticals. Designed and promoted a directed cellular development system for hemapoietic progenitor cells.

Mba, Entrepreneurship, Health Industry Management, Marketing, And Strategy

Bs, Biochemistry & Cellular Biology